Form 4: ProAssurance Corp Merger Completes, Director Di Piazza Reports

ProAssurance Corporation's merger with The Doctors Company has been finalized, with director Samuel A. Di Piazza Jr. reporting the conversion of his deferred shares into cash consideration.

Summary

• This filing is a Form 4, reporting changes in beneficial ownership of securities.
• Samuel A. Di Piazza Jr., a Director of ProAssurance Corporation, reported transactions on June 26, 2026.
• The transactions are related to the merger between ProAssurance Corporation and The Doctors Company, which was effective on June 26, 2026.
• Deferred shares held by Mr. Di Piazza were converted into the right to receive cash.
• The conversion price for each share of ProAssurance Corporation common stock was $25.00 in cash.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive filing as it confirms the completion of a significant merger event, providing clarity on the transaction's execution and shareholder value realization through cash consideration.

Positives

• The merger between ProAssurance Corporation and The Doctors Company has been successfully completed.
• Director Samuel A. Di Piazza Jr.'s deferred stock compensation plan shares were converted into cash, indicating the completion of the merger consideration payout.

Future Outlook

The filing primarily reports on the completion of a merger and the conversion of securities, rather than providing forward-looking financial guidance.

Industry Context

StockSavvy.ai notes that this Form 4 filing confirms the successful completion of the ProAssurance Corporation merger with The Doctors Company, a significant consolidation event in the healthcare liability insurance sector.

Stakeholder Impact

• Shareholders: Received $25.00 per share in cash for their ProAssurance Corporation common stock.
• Management and Employees: The merger signifies a change in corporate structure, with ProAssurance Corporation becoming a subsidiary of The Doctors Company.
• Creditors: The financial obligations and relationships with creditors will transition under the new ownership structure.

Next Steps

• ProAssurance Corporation will now operate as a wholly owned subsidiary of The Doctors Company.
• Shareholders who held ProAssurance Corporation common stock have received $25.00 per share in cash.

Key Dates

Keywords

ProAssurance Corporation, Form 4, SEC Filing, Merger, Director, Deferred Stock, Beneficial Ownership, The Doctors Company, Samuel A. Di Piazza Jr.